My name is Susanne Schuurman, and I am the Head of Market Access at Arex Advisor, a consultancy company with Nordic roots and international expertise.
I am an experienced consultant in the area of market access and HTA, responsible for the content expertise in a variety of market access projects as well as project management. The main area of focus are treatments for rare diseases and orphan drugs.
I have mainly been involved in early strategy evidence generation, HTA landscape assessments, (HTA) reimbursement dossier development and adapting economic models to local settings. In addition, conducted interviews with payers and patients and held advisory boards for market access purpose and value message testing, as well as competitive intelligence.